Comparison of 24-hour and 8-hour Infusion of Nafamostat Mesilate for the Prevention of Post-ERCP Pancreatitis: A Prospective Randomized Comparison Trial

被引：0
|
作者：
Kim, S. J. [1 ]
Kang, D. H. [2 ]
Kim, H. W. [1 ]
Choi, C. W. [1 ]
Park, S. B. [1 ]
Song, B. J. [1 ]
Shin, Y. S. [1 ]
机构：
[1] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea
[2] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1378 / 1378
页数：1
相关论文
共 50 条
  • [1] Prophylasix of Post-ERCP Pancreatitis With Nafamostat Mesilate: Comparison of 24-Hour and 8-Hour Infusion of Nafamostat Mesilate: a Prospective Randomized Comparison Trial
    Kim, Wan Chul
    Jeon, Joon Ho
    Shin, Jae Gyu
    Nam, Hyeong Seok
    Kang, Dae Hwan
    Kim, Hyung Wook
    Choi, Cheol Woong
    Park, Su Bum
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB160 - AB160
  • [2] Prevention of post-ercp pancreatitis by using nafamostat mesilate: comparison of 8-hour infusion versus 24-hour infusion
    Choi, Yu Yi
    Kang, Dae Hwan
    Choi, Cheol Woong
    Park, Su Bum
    Hong, Joung Boom
    Kim, Dong Jun
    Shin, Young Shin
    Kang, Dong Ku
    Kim, Min Dae
    Jeong, Eul Jo
    Kim, Hyung Wook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 138 - 138
  • [3] Nafamostat mesilate for prevention of Post-ERCP pancreatitis
    Yoo, Kyo-Sang
    Moon, Joon Ho
    Park, Kwang Hyuk
    Chung, Yong Woo
    Kim, Kyoung Oh
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Lee, Jin
    Park, Choong Kee
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB212 - AB212
  • [4] Nafamostat mesilate for prevention of post-ERCP pancreatitis
    Ybo, Kyo-Sang
    Choi, Won Sub
    Chung, Woo
    Kim, Kyourig On
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Lee, Jin
    Park, Choong Kee
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB153 - AB153
  • [5] A Randomized Comparative Study of 24-and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Prospective Randomized Comparison Trial
    Kim, Su Jin
    Kang, Dae Hwan
    Kim, Hyung Wook
    Choi, Cheol Woong
    Park, Su Bum
    Song, Byeong Jun
    Nam, Hyeong Seok
    PANCREAS, 2016, 45 (08) : 1179 - 1183
  • [6] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Joo Seong Kim
    Sang Hyub Lee
    Namyoung Park
    Gunn Huh
    Jung Won Chun
    Jin Ho Choi
    In Rae Cho
    Woo Hyun Paik
    Ji Kon Ryu
    Yong-Tae Kim
    BMC Gastroenterology, 22
  • [7] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, J. S.
    Lee, S. H.
    Park, N.
    Huh, G.
    Chun, J. W.
    Choi, J. H.
    Cho, I. R.
    Paik, W. H.
    Ryu, J. K.
    Kim, Y. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 134 - 134
  • [8] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, Joo Seong
    Lee, Sang Hyub
    Park, Namyoung
    Huh, Gunn
    Chun, Jung Won
    Choi, Jin Ho
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [9] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [10] Use of nafamostat mesilate and gabexate mesylate in the prevention of post-ERCP pancreatitis and risk factor analysis: A prospective, randomized trial
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang-Ha
    Song, Geun-Am
    Eum, Jae-Sup
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB244 - AB245
12345